Patents by Inventor Moon Cheol KANG

Moon Cheol KANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION COMPRISING IMMUNOGLOBULIN FC-FUSED INTERLEUKIN-7 FUSION PROTEIN FOR PREVENTING OR TREATING HUMAN PAPILLOMAVIRUS-CAUSED DISEASES
    Publication number: 20250257108
    Abstract: The present invention relates to a pharmaceutical composition comprising an immunoglobulin Fc region and an IL-7 fusion protein. Specifically, when a fusion protein comprising the immunoglobulin Fc region and IL-7 is administered to an affected area, a strong immune response is induced in the body and thus allows human papillomavirus-caused diseases to be prevented or treated.
    Type: Application
    Filed: January 17, 2025
    Publication date: August 14, 2025
    Applicant: GENEXINE, INC.
    Inventors: Moon Cheol KANG, Young Woo CHOI, Donghoon CHOI, Young Chul SUNG
  • Virus infection using pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion protein
    Patent number: 12357677
    Abstract: The present invention relates to a pharmaceutical composition comprising an interleukin-7 fusion protein to which an immunoglobulin Fc region has been fused for preventing or treating diseases caused by influenza virus A. The fusion protein comprising the immunoglobulin Fc region and IL-7 according to the present invention protects the body from infection due to influenza virus A and thus can treat diseases which can be caused by the virus.
    Type: Grant
    Filed: June 13, 2022
    Date of Patent: July 15, 2025
    Assignee: GENEXINE, INC.
    Inventors: Moon Cheol Kang, Young Woo Choi, Donghoon Choi, Young Chul Sung
  • PHARMACEUTICAL COMPOSITION COMPRISING IMMUNOGLOBULIN FC-FUSED INTERLEUKIN-7 FUSION PROTEIN FOR PREVENTING OR TREATING HUMAN PAPILLOMAVIRUS-CAUSED DISEASES
    Publication number: 20240018205
    Abstract: The present invention relates to a pharmaceutical composition comprising an immunoglobulin Fc region and an IL-7 fusion protein. Specifically, when a fusion protein comprising the immunoglobulin Fc region and IL-7 is administered to an affected area, a strong immune response is induced in the body and thus allows human papillomavirus-caused diseases to be prevented or treated.
    Type: Application
    Filed: June 1, 2023
    Publication date: January 18, 2024
    Applicant: GENEXINE, INC.
    Inventors: Moon Cheol KANG, Young Woo CHOI, Donghoon CHOI, Young Chul SUNG
  • Pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion protein for preventing or treating human papillomavirus-caused diseases
    Patent number: 11708399
    Abstract: The present invention relates to a pharmaceutical composition comprising an immunoglobulin Fc region and an IL-7 fusion protein. Specifically, when a fusion protein comprising the immunoglobulin Fc region and IL-7 is administered to an affected area, a strong immune response is induced in the body and thus allows human papillomavirus-caused diseases to be prevented or treated.
    Type: Grant
    Filed: December 2, 2016
    Date of Patent: July 25, 2023
    Assignee: GENEXINE, INC.
    Inventors: Moon Cheol Kang, Young Woo Choi, Donghoon Choi, Young Chul Sung
  • METHOD FOR PREVENTING OR TREATING INFLUENZA VIRUS INFECTION USING PHARMACEUTICAL COMPOSITION COMPRISING IMMUNOGLOBULIN FC-FUSED INTERLEUKIN-7 FUSION PROTEIN
    Publication number: 20230015320
    Abstract: The present invention relates to a pharmaceutical composition comprising an interleukin-7 fusion protein to which an immunoglobulin Fc region has been fused for preventing or treating diseases caused by influenza virus A. The fusion protein comprising the immunoglobulin Fc region and IL-7 according to the present invention protects the body from infection due to influenza virus A and thus can treat diseases which can be caused by the virus.
    Type: Application
    Filed: June 13, 2022
    Publication date: January 19, 2023
    Applicant: GENEXINE, INC.
    Inventors: Moon Cheol KANG, Young Woo CHOI, Donghoon CHOI, Young Chul SUNG
  • Method for preventing or treating influenza virus infection using pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion protein
    Patent number: 11357827
    Abstract: The present invention relates to a pharmaceutical composition comprising an interleukin-7 fusion protein to which an immunoglobulin Fc region has been fused for preventing or treating diseases caused by influenza virus A. The fusion protein comprising the immunoglobulin Fc region and IL-7 according to the present invention protects the body from infection due to influenza virus A and thus can treat diseases which can be caused by the virus.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: June 14, 2022
    Assignee: Genexine, Inc.
    Inventors: Moon Cheol Kang, Young Woo Choi, Donghoon Choi, Young Chul Sung
  • PHARMACEUTICAL COMPOSITION COMPRISING IMMUNOGLOBULIN FC-FUSED INTERLEUKIN-7 FUSION PROTEIN FOR PREVENTING OR TREATING INFECTION FROM INFLUENZA VIRUS
    Publication number: 20180353573
    Abstract: The present invention relates to a pharmaceutical composition comprising an interleukin-7 fusion protein to which an immunoglobulin Fc region has been fused for preventing or treating diseases caused by influenza virus A. The fusion protein comprising the immunoglobulin Fc region and IL-7 according to the present invention protects the body from infection due to influenza virus A and thus can treat diseases which can be caused by the virus.
    Type: Application
    Filed: November 30, 2016
    Publication date: December 13, 2018
    Applicant: GENEXINE, INC.
    Inventors: Moon Cheol KANG, Young Woo CHOI, Donghoon CHOI, Young Chul SUNG
  • PHARMACEUTICAL COMPOSITION COMPRISING IMMUNOGLOBULIN FC-FUSED INTERLEUKIN-7 FUSION PROTEIN FOR PREVENTING OR TREATING HUMAN PAPILLOMAVIRUS-CAUSED DISEASES
    Publication number: 20180319858
    Abstract: The present invention relates to a pharmaceutical composition comprising an immunoglobulin Fc region and an IL-7 fusion protein. Specifically, when a fusion protein comprising the immunoglobulin Fc region and IL-7 is administered to an affected area, a strong immune response is induced in the body and thus allows human papillomavirus-caused diseases to be prevented or treated.
    Type: Application
    Filed: December 2, 2016
    Publication date: November 8, 2018
    Applicant: GENEXINE, INC.
    Inventors: Moon Cheol KANG, Young Woo CHOI, Donghoon CHOI, Young Chul SUNG
  • Chiller for canister
    Patent number: 9469461
    Abstract: Disclosed is a chiller for a canister including: a drum-shaped tray with an open upper part; an inner casing inserted in the tray with a given space between the inside wall surface of the tray and the inner casing for receiving the canister; and a drainage container arranged between the inner casing and the tray for collecting cooling water discharged from the inner casing, thus preventing dew from being produced on the surface of the tray.
    Type: Grant
    Filed: May 10, 2013
    Date of Patent: October 18, 2016
    Assignee: Chemtura Corporation
    Inventors: Jang Won Kim, Woo Ho Son, Kwang Sik You, Moon Cheol Kang
  • CHILLER FOR CANISTER
    Publication number: 20160016719
    Abstract: Disclosed is a chiller for a canister including: a drum-shaped tray with an open upper part; an inner casing inserted in the tray with a given space between the inside wall surface of the tray and the inner casing for receiving the canister; and a drainage container arranged between the inner casing and the tray for collecting cooling water discharged from the inner casing, thus preventing dew from being produced on the surface of the tray.
    Type: Application
    Filed: May 10, 2013
    Publication date: January 21, 2016
    Inventors: Jang Won KIM, Woo Ho SON, Kwang Sik YOU, Moon Cheol KANG